Mechanisms of dendritic cell trafficking across the blood-brain barrier

Divya Sagar, Catherine Foss, Rasha El Baz, Martin Gilbert Pomper, Zafar K. Khan, Pooja Jain

Research output: Contribution to journalArticle

Abstract

Although the central nervous system (CNS) is considered to be an immunoprivileged site, it is susceptible to a host of autoimmune as well as neuroinflammatory disorders owing to recruitment of immune cells across the blood-brain barrier into perivascular and parenchymal spaces. Dendritic cells (DCs), which are involved in both primary and secondary immune responses, are the most potent immune cells in terms of antigen uptake and processing as well as presentation to T cells. In light of the emerging importance of DC traficking into the CNS, these cells represent good candidates for targeted immunotherapy against various neuroinflammatory diseases. This review focuses on potential physiological events and receptor interactions between DCs and the microvascular endothelial cells of the brain as they transmigrate into the CNS during degeneration and injury. A clear understanding of the underlying mechanisms involved in DC migration may advance the development of new therapies that manipulate these mechanistic properties via pharmacologic intervention. Furthermore, therapeutic validation should be in concurrence with the molecular imaging techniques that can detect migration of these cells in vivo. Since the use of noninvasive methods to image migration of DCs into CNS has barely been explored, we highlighted potential molecular imaging techniques to achieve this goal. Overall, information provided will bring this important leukocyte population to the forefront as key players in the immune cascade in the light of the emerging contribution of DCs to CNS health and disease.

Original languageEnglish (US)
Pages (from-to)74-94
Number of pages21
JournalJournal of NeuroImmune Pharmacology
Volume7
Issue number1
DOIs
StatePublished - Mar 2012

Fingerprint

Blood-Brain Barrier
Dendritic Cells
Central Nervous System
Molecular Imaging
Antigen Presentation
Cell Movement
Central Nervous System Diseases
Immunotherapy
Leukocytes
Endothelial Cells
T-Lymphocytes
Health
Wounds and Injuries
Brain
Therapeutics
Population

Keywords

  • Blood-brain barrier
  • Dendritic cell trafficking
  • Lectins and integrins
  • Microvascular endothelial cells
  • Molecular imaging
  • Neuroinflammation

ASJC Scopus subject areas

  • Pharmacology
  • Immunology and Allergy
  • Immunology
  • Neuroscience (miscellaneous)

Cite this

Mechanisms of dendritic cell trafficking across the blood-brain barrier. / Sagar, Divya; Foss, Catherine; El Baz, Rasha; Pomper, Martin Gilbert; Khan, Zafar K.; Jain, Pooja.

In: Journal of NeuroImmune Pharmacology, Vol. 7, No. 1, 03.2012, p. 74-94.

Research output: Contribution to journalArticle

Sagar, Divya ; Foss, Catherine ; El Baz, Rasha ; Pomper, Martin Gilbert ; Khan, Zafar K. ; Jain, Pooja. / Mechanisms of dendritic cell trafficking across the blood-brain barrier. In: Journal of NeuroImmune Pharmacology. 2012 ; Vol. 7, No. 1. pp. 74-94.
@article{e85645d1409240f7aa350a115434df70,
title = "Mechanisms of dendritic cell trafficking across the blood-brain barrier",
abstract = "Although the central nervous system (CNS) is considered to be an immunoprivileged site, it is susceptible to a host of autoimmune as well as neuroinflammatory disorders owing to recruitment of immune cells across the blood-brain barrier into perivascular and parenchymal spaces. Dendritic cells (DCs), which are involved in both primary and secondary immune responses, are the most potent immune cells in terms of antigen uptake and processing as well as presentation to T cells. In light of the emerging importance of DC traficking into the CNS, these cells represent good candidates for targeted immunotherapy against various neuroinflammatory diseases. This review focuses on potential physiological events and receptor interactions between DCs and the microvascular endothelial cells of the brain as they transmigrate into the CNS during degeneration and injury. A clear understanding of the underlying mechanisms involved in DC migration may advance the development of new therapies that manipulate these mechanistic properties via pharmacologic intervention. Furthermore, therapeutic validation should be in concurrence with the molecular imaging techniques that can detect migration of these cells in vivo. Since the use of noninvasive methods to image migration of DCs into CNS has barely been explored, we highlighted potential molecular imaging techniques to achieve this goal. Overall, information provided will bring this important leukocyte population to the forefront as key players in the immune cascade in the light of the emerging contribution of DCs to CNS health and disease.",
keywords = "Blood-brain barrier, Dendritic cell trafficking, Lectins and integrins, Microvascular endothelial cells, Molecular imaging, Neuroinflammation",
author = "Divya Sagar and Catherine Foss and {El Baz}, Rasha and Pomper, {Martin Gilbert} and Khan, {Zafar K.} and Pooja Jain",
year = "2012",
month = "3",
doi = "10.1007/s11481-011-9302-7",
language = "English (US)",
volume = "7",
pages = "74--94",
journal = "Journal of NeuroImmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Mechanisms of dendritic cell trafficking across the blood-brain barrier

AU - Sagar, Divya

AU - Foss, Catherine

AU - El Baz, Rasha

AU - Pomper, Martin Gilbert

AU - Khan, Zafar K.

AU - Jain, Pooja

PY - 2012/3

Y1 - 2012/3

N2 - Although the central nervous system (CNS) is considered to be an immunoprivileged site, it is susceptible to a host of autoimmune as well as neuroinflammatory disorders owing to recruitment of immune cells across the blood-brain barrier into perivascular and parenchymal spaces. Dendritic cells (DCs), which are involved in both primary and secondary immune responses, are the most potent immune cells in terms of antigen uptake and processing as well as presentation to T cells. In light of the emerging importance of DC traficking into the CNS, these cells represent good candidates for targeted immunotherapy against various neuroinflammatory diseases. This review focuses on potential physiological events and receptor interactions between DCs and the microvascular endothelial cells of the brain as they transmigrate into the CNS during degeneration and injury. A clear understanding of the underlying mechanisms involved in DC migration may advance the development of new therapies that manipulate these mechanistic properties via pharmacologic intervention. Furthermore, therapeutic validation should be in concurrence with the molecular imaging techniques that can detect migration of these cells in vivo. Since the use of noninvasive methods to image migration of DCs into CNS has barely been explored, we highlighted potential molecular imaging techniques to achieve this goal. Overall, information provided will bring this important leukocyte population to the forefront as key players in the immune cascade in the light of the emerging contribution of DCs to CNS health and disease.

AB - Although the central nervous system (CNS) is considered to be an immunoprivileged site, it is susceptible to a host of autoimmune as well as neuroinflammatory disorders owing to recruitment of immune cells across the blood-brain barrier into perivascular and parenchymal spaces. Dendritic cells (DCs), which are involved in both primary and secondary immune responses, are the most potent immune cells in terms of antigen uptake and processing as well as presentation to T cells. In light of the emerging importance of DC traficking into the CNS, these cells represent good candidates for targeted immunotherapy against various neuroinflammatory diseases. This review focuses on potential physiological events and receptor interactions between DCs and the microvascular endothelial cells of the brain as they transmigrate into the CNS during degeneration and injury. A clear understanding of the underlying mechanisms involved in DC migration may advance the development of new therapies that manipulate these mechanistic properties via pharmacologic intervention. Furthermore, therapeutic validation should be in concurrence with the molecular imaging techniques that can detect migration of these cells in vivo. Since the use of noninvasive methods to image migration of DCs into CNS has barely been explored, we highlighted potential molecular imaging techniques to achieve this goal. Overall, information provided will bring this important leukocyte population to the forefront as key players in the immune cascade in the light of the emerging contribution of DCs to CNS health and disease.

KW - Blood-brain barrier

KW - Dendritic cell trafficking

KW - Lectins and integrins

KW - Microvascular endothelial cells

KW - Molecular imaging

KW - Neuroinflammation

UR - http://www.scopus.com/inward/record.url?scp=84860730370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860730370&partnerID=8YFLogxK

U2 - 10.1007/s11481-011-9302-7

DO - 10.1007/s11481-011-9302-7

M3 - Article

VL - 7

SP - 74

EP - 94

JO - Journal of NeuroImmune Pharmacology

JF - Journal of NeuroImmune Pharmacology

SN - 1557-1890

IS - 1

ER -